|
GB1506200A
(en)
*
|
1975-04-30 |
1978-04-05 |
Farmaceutici Italia |
Glycosides
|
|
GB1509875A
(en)
*
|
1976-06-14 |
1978-05-04 |
Farmaceutici Italia |
Optically active anthracyclinones and anthracycline glycosides
|
|
US4161480A
(en)
*
|
1978-06-05 |
1979-07-17 |
G. D. Searle & Co. |
Intermediates for the synthesis of 4-demethoxydaunorubicin
|
|
US4201773A
(en)
*
|
1978-07-26 |
1980-05-06 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
|
|
IL55431A
(en)
*
|
1978-08-24 |
1982-07-30 |
Yeda Res & Dev |
Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them
|
|
NL8001417A
(nl)
*
|
1979-03-17 |
1980-09-19 |
Erba Farmitalia |
Antitumorglycosiden.
|
|
BE884828A
(fr)
*
|
1979-08-20 |
1981-02-19 |
Hoffmann La Roche |
Derives de naphtacene
|
|
CA1154013A
(en)
*
|
1979-09-01 |
1983-09-20 |
Alberto Bargiotti |
Antitumor glycosides, their preparation, use and compositions thereof
|
|
DE3100968A1
(de)
*
|
1980-01-16 |
1982-01-14 |
Farmitalia Carlo Erba S.p.A., 20159 Milano |
Anthracyclinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4348388A
(en)
*
|
1980-04-02 |
1982-09-07 |
G.D. Searle & Co. |
11-Amino-11-deoxydaunorubicin and analogs
|
|
ZA814722B
(en)
*
|
1980-07-18 |
1982-07-28 |
Hoffmann La Roche |
Novel anthracycline glycosides
|
|
GB8317037D0
(en)
*
|
1983-06-23 |
1983-07-27 |
Erba Farmitalia |
6-deoxyanthracyclines
|
|
US5138042A
(en)
*
|
1981-05-28 |
1992-08-11 |
Farmitalia Carlo Erba S.P.A. |
6-deoxyanthracyclines
|
|
IT1210476B
(it)
*
|
1981-05-28 |
1989-09-14 |
Erba Farmitalia |
Antracicline.
|
|
US4563444A
(en)
*
|
1982-05-26 |
1986-01-07 |
Farmitalia Carlo Erba S.P.A. |
Anthracycline glycosides, use and compositions containing same
|
|
US4604381A
(en)
*
|
1982-07-16 |
1986-08-05 |
Farmitalia Carlo Erba S.P.A. |
4-demethoxy-13-dihydrodaunorubicin and use thereof
|
|
US4562177A
(en)
*
|
1982-08-17 |
1985-12-31 |
The Ohio State University Research Foundation |
3'-Amino-2' halo-anthracycline antibiotics
|
|
US4564674A
(en)
*
|
1983-10-31 |
1986-01-14 |
Sagami Chemical Research Center |
Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process
|
|
US4496485A
(en)
*
|
1983-11-25 |
1985-01-29 |
G. D. Searle & Co. |
Asymmetric 7-O-(substituted acetyl)-4-demethoxydaunomycinones
|
|
US4537882A
(en)
*
|
1984-05-10 |
1985-08-27 |
Ohio State University |
4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
|
|
US4697005A
(en)
*
|
1985-03-20 |
1987-09-29 |
Ohio State University Research Foundation |
1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
|
|
US5124317A
(en)
*
|
1985-08-02 |
1992-06-23 |
Farmitalia Carlo Erba S.P.A. |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
|
|
NZ224252A
(en)
*
|
1987-04-21 |
1991-09-25 |
Erba Carlo Spa |
An anthracycline glycoside and its preparation
|
|
JPS63191263U
(enExample)
*
|
1987-05-29 |
1988-12-09 |
|
|
|
GB2212154B
(en)
*
|
1987-11-10 |
1991-03-27 |
Erba Carlo Spa |
New 4-demethoxy anthracycline derivatives
|
|
GB8803301D0
(en)
*
|
1988-02-12 |
1988-03-09 |
Erba Carlo Spa |
Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
|
|
GB8808475D0
(en)
*
|
1988-04-11 |
1988-05-11 |
Erba Carlo Spa |
Process for preparing 4-demethoxydauno-mycinone
|
|
GB8818167D0
(en)
*
|
1988-07-29 |
1988-09-01 |
Erba Carlo Spa |
Novel 4-substituted anthracyclinones & process for their preparation
|
|
WO1993018050A1
(en)
*
|
1992-03-02 |
1993-09-16 |
Pfizer Inc. |
Sugar derivatives of macrolides
|
|
WO2004033666A2
(en)
*
|
2002-10-11 |
2004-04-22 |
Board Of Regents, The University Of Texas System |
Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases
|
|
EP1845974A1
(en)
|
2005-01-21 |
2007-10-24 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
US8883790B2
(en)
|
2006-10-12 |
2014-11-11 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
EP2073803B1
(en)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
SG172363A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Synthesis of purine nucleosides
|
|
KR20110099138A
(ko)
*
|
2008-12-23 |
2011-09-06 |
파마셋 인코포레이티드 |
뉴클레오시드 포스포르아미데이트
|
|
KR20110098849A
(ko)
*
|
2008-12-23 |
2011-09-01 |
파마셋 인코포레이티드 |
뉴클레오시드 유사체
|
|
EP2719708B1
(en)
|
2009-11-13 |
2017-10-25 |
Daiichi Sankyo Europe GmbH |
Material and methods for treating or preventing HER-3 associated diseases
|
|
PL2552930T3
(pl)
|
2010-03-31 |
2016-02-29 |
Gilead Pharmasset Llc |
Krystaliczny 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1-(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian (S)-izopropylu
|
|
EP2601220A2
(en)
|
2010-08-06 |
2013-06-12 |
U3 Pharma GmbH |
Use of her3 binding agents in prostate treatment
|
|
DE102011113652A1
(de)
|
2011-09-19 |
2013-03-21 |
Heraeus Precious Metals Gmbh & Co. Kg |
Kristallisierung von Idarubicinhydrochlorid
|
|
EP3311827B1
(en)
|
2011-10-03 |
2023-01-04 |
Canqura Oncology Ab |
Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
|
|
WO2014163558A1
(en)
|
2013-04-01 |
2014-10-09 |
Moreinx Ab |
Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
|
|
EP3669890A1
(en)
|
2018-12-18 |
2020-06-24 |
Croda International PLC |
Filamentous nanoparticles having vaccine adjuvant effect
|